Dr. Madan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Banner MD Anderson Cancer Center
2946 E Banner Gateway Drive
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-3682
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
Mayo Clinic College of MedicinePost-Doctoral Fellowship, 2009 - 2011
Rush University Medical CenterFellowship, Hospice and Palliative Medicine, 2007 - 2008
Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2004 - 2007
Rajah Muthiah Medical CollegeClass of 2002
Certifications & Licensure
AZ State Medical License 2018 - 2026
TX State Medical License 2014 - 2023
MN State Medical License 2008 - 2012
NJ State Medical License 2005 - 2009
IL State Medical License 2007 - 2008
Publications & Presentations
PubMed
- A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory mult...Hang Quach, Gurdeep Parmar, Enrique M Ocio, H Miles Prince, Albert Oriol
Haematologica. 2024-12-01 - 1 citationsEfficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.Darrell White, Gary J Schiller, Sumit Madan, Suzanne Lentzsch, Evgeni Chubar
Frontiers in Oncology. 2024-01-01 - 4 citationsSpleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavot...Leo I Gordon, Reem Karmali, Jason B Kaplan, Rakesh Popat, Howard A Burris 3rd
Oncotarget. 2023-01-26
Press Mentions
Harpoon Therapeutics : ASH2022 Interim ClinicalDecember 12th, 2022
Acetylon Presents Data on the Use of HDAC6 Inhibitors Ricolinostat (ACY-1215) and ACY-241 in Combination with Pomalidomide and Dexamethasone for the Treatment of Multiple MyelomaJune 13th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
